The GV and WuXi AppTec-backed operator of remote laboratory manager has secured $56.1m of new funding from investors including Eli Lilly.
Pharmaceutical firm Eli Lilly participated in a $56.1m series B round for Strateos, a US-based operator of remotely controlled laboratory facilities, on Tuesday.
The round was co-led by venture capital firms DCVC and Lux Capital and included Ally Bridge Group, Black Diamond Ventures, Mack & Co and Castor Ventures.
Strateos has built two automated laboratory facilities that can be remotely controlled through software and which contain advanced robotics and scientific instruments. Its SmartLab Platform is used by life sciences researchers…
